MiMedx Plantar Fasciitis Clinical Trial Underway

MiMedx initiated a Phase III study to evaluate AmnioFix Injectable vs. placebo in the treatment of Plantar Fasciitis.

The company submitted an Investigational New Drug amendment to FDA requesting the trial based on interim results of a previous IND Phase IIB trial.

The 18-month prospective, double-blind, randomized controlled trial will...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us